Trademark: 97282621
Word
ALLYX THERAPEUTICS
Status
Pending
Status Code
730
Status Date
Wednesday, January 3, 2024
Serial Number
97282621
Mark Type
4000
Filing Date
Thursday, February 24, 2022
Published for Opposition
Tuesday, January 17, 2023

Trademark Owner History
Allyx Therapeutics, Inc. - Owner At Publication

Classifications
5 Pharmaceutical preparations for use in the prevention and treatment of neurodegenerative diseases, but not including products for the treatment of hemophilia
"THERAPEUTICS"

Trademark Events
Jan 5, 2024
Notice Of Approval Of Extension Request E-Mailed
Jan 3, 2024
Sou Extension 1 Granted
Jan 3, 2024
Sou Extension 1 Filed
Jan 3, 2024
Sou Teas Extension Received
Jul 11, 2023
Noa E-Mailed - Sou Required From Applicant
May 28, 2023
Extension Of Time To Oppose Process - Terminated
Apr 18, 2023
Changes/Corrections After Pub Approval Entered
Apr 17, 2023
Assigned To Petition Staff
Mar 31, 2023
Teas Post Publication Amendment Received
Feb 10, 2023
Extension Of Time To Oppose Received
Jan 17, 2023
Official Gazette Publication Confirmation E-Mailed
Jan 17, 2023
Published For Opposition
Dec 28, 2022
Notification Of Notice Of Publication E-Mailed
Dec 14, 2022
Approved For Pub - Principal Register
Dec 14, 2022
Examiner's Amendment Entered
Dec 14, 2022
Notification Of Examiners Amendment E-Mailed
Dec 14, 2022
Examiners Amendment E-Mailed
Dec 14, 2022
Examiners Amendment -Written
Dec 8, 2022
Assigned To Examiner
Mar 2, 2022
New Application Office Supplied Data Entered
Feb 28, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24